NYSE:GSK GSK Q3 2026 Earnings Report $48.25 -1.10 (-2.22%) Closing price 09/30/2026 03:59 PM EasternExtended Trading$47.78 -0.47 (-0.98%) As of 06:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast GSK EPS ResultsActual EPSN/AConsensus EPS $1.37Beat/MissN/AOne Year Ago EPSN/AGSK Revenue ResultsActual RevenueN/AExpected Revenue$11.95 billionBeat/MissN/AYoY Revenue GrowthN/AGSK Announcement DetailsQuarterQ3 2026Date10/28/2026TimeBefore Market OpensConference Call DateWednesday, October 28, 2026Conference Call Time3:00AM ETConference Call ResourcesEarnings HistoryCompany Profile GSK Earnings HeadlinesGSK India sets Guinness World Record with massive healthcare mosaic in MumbaiSeptember 29 at 1:29 PM | msn.comGSK India sets Guinness World Records title with giant brochure mosaic on World Heart DaySeptember 29 at 1:29 PM | msn.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 1 at 1:00 AM | Investors Alley (Ad)GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciatedSeptember 29 at 8:29 AM | proactiveinvestors.comGSK retains ‘buy' rating at Jefferies as B7H3 cancer programme seen as underappreciatedSeptember 29 at 7:59 AM | proactiveinvestors.comGSK PLC Sponsored ADR (NYSE:GSK) Stock Has Consensus Price Target of $56.50September 25, 2026 | americanbankingnews.comSee More GSK Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GSK? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GSK and other key companies, straight to your email. Email Address About GSKGSK (NYSE:GSK) plc is a global biopharmaceutical company headquartered in Brentford, England. The company develops and commercializes medicines and vaccines, with research and commercial activities focused on infectious diseases, respiratory conditions, immunology, oncology and HIV. Its products are distributed across markets worldwide through healthcare providers, public health systems and pharmacies. GSK’s portfolio includes vaccines such as Shingrix for shingles and Arexvy for respiratory syncytial virus (RSV), as well as specialty medicines including Trelegy for chronic respiratory disease and Nucala for severe asthma and related inflammatory conditions. Through ViiV Healthcare, in which GSK is the majority shareholder, the company also provides HIV treatments, including therapies based on dolutegravir. The company traces its modern history to the 2000 merger of Glaxo Wellcome and SmithKline Beecham. In 2022, GSK separated its consumer healthcare business, which became Haleon, allowing GSK to focus exclusively on biopharmaceuticals. GSK is led by Chief Executive Officer Emma Walmsley, who has held the role since 2017.View GSK ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundArhaus Has New Momentum—Could Other Furniture Stocks Be Next?Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
